Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis

BACKGROUND: Adjuvant therapy is a promising treatment to improve the prognosis of cancer patients, however, the evidence base driving recommendations for adjuvant radiotherapy (ART) or chemotherapy (ACT) in retroperitoneal sarcomas (RPS) primarily hinges on observational data. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangji, Wu, Tong, Xiao, Mengmeng, Wu, Shanshan, Min, Li, Luo, Chenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496039/
https://www.ncbi.nlm.nih.gov/pubmed/34620197
http://dx.doi.org/10.1186/s13014-021-01774-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496039/
https://www.ncbi.nlm.nih.gov/pubmed/34620197
http://dx.doi.org/10.1186/s13014-021-01774-w

Ejemplares similares